This year US FDA has approved BAVENCIO for the maintenance treatment of patients with locally advanced or metastatic UC... Dec 12
Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 ... May 14
Asia's first company to sponsor clinical trial of combination therapy of anti-cancer microbiome and anti-PD1/anti-PD-L1 drug... Apr 20
New subgroup analyses for first-line treatment of advanced renal cell carcinoma with BAVENCIO®* (avelumab) in combination with axitinib... Sep 23
-Advertisements-